232 related articles for article (PubMed ID: 12606579)
1. FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts.
Bois PR; Grosveld GC
EMBO J; 2003 Mar; 22(5):1147-57. PubMed ID: 12606579
[TBL] [Abstract][Full Text] [Related]
2. Follicle-stimulating hormone promotes nuclear exclusion of the forkhead transcription factor FoxO1a via phosphatidylinositol 3-kinase in porcine granulosa cells.
Cunningham MA; Zhu Q; Unterman TG; Hammond JM
Endocrinology; 2003 Dec; 144(12):5585-94. PubMed ID: 12960025
[TBL] [Abstract][Full Text] [Related]
3. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting.
Rena G; Prescott AR; Guo S; Cohen P; Unterman TG
Biochem J; 2001 Mar; 354(Pt 3):605-12. PubMed ID: 11237865
[TBL] [Abstract][Full Text] [Related]
4. Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins.
Richards JS; Sharma SC; Falender AE; Lo YH
Mol Endocrinol; 2002 Mar; 16(3):580-99. PubMed ID: 11875118
[TBL] [Abstract][Full Text] [Related]
5. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity.
Dijkers PF; Birkenkamp KU; Lam EW; Thomas NS; Lammers JW; Koenderman L; Coffer PJ
J Cell Biol; 2002 Feb; 156(3):531-42. PubMed ID: 11815629
[TBL] [Abstract][Full Text] [Related]
6. Akt modulates STAT3-mediated gene expression through a FKHR (FOXO1a)-dependent mechanism.
Kortylewski M; Feld F; Krüger KD; Bahrenberg G; Roth RA; Joost HG; Heinrich PC; Behrmann I; Barthel A
J Biol Chem; 2003 Feb; 278(7):5242-9. PubMed ID: 12456685
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of Rho/ROCK signaling is crucial for the nuclear accumulation of FKHR and myoblast fusion.
Nishiyama T; Kii I; Kudo A
J Biol Chem; 2004 Nov; 279(45):47311-9. PubMed ID: 15322110
[TBL] [Abstract][Full Text] [Related]
8. AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.
Li P; Lee H; Guo S; Unterman TG; Jenster G; Bai W
Mol Cell Biol; 2003 Jan; 23(1):104-18. PubMed ID: 12482965
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.
Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG
Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146
[TBL] [Abstract][Full Text] [Related]
10. Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells.
Mazumdar A; Kumar R
FEBS Lett; 2003 Jan; 535(1-3):6-10. PubMed ID: 12560069
[TBL] [Abstract][Full Text] [Related]
11. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1).
Dijkers PF; Medema RH; Pals C; Banerji L; Thomas NS; Lam EW; Burgering BM; Raaijmakers JA; Lammers JW; Koenderman L; Coffer PJ
Mol Cell Biol; 2000 Dec; 20(24):9138-48. PubMed ID: 11094066
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.
Abid MR; Guo S; Minami T; Spokes KC; Ueki K; Skurk C; Walsh K; Aird WC
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):294-300. PubMed ID: 14656735
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.
Schmidt M; Fernandez de Mattos S; van der Horst A; Klompmaker R; Kops GJ; Lam EW; Burgering BM; Medema RH
Mol Cell Biol; 2002 Nov; 22(22):7842-52. PubMed ID: 12391153
[TBL] [Abstract][Full Text] [Related]
14. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway.
Nakae J; Park BC; Accili D
J Biol Chem; 1999 Jun; 274(23):15982-5. PubMed ID: 10347145
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding.
Zhang X; Gan L; Pan H; Guo S; He X; Olson ST; Mesecar A; Adam S; Unterman TG
J Biol Chem; 2002 Nov; 277(47):45276-84. PubMed ID: 12228231
[TBL] [Abstract][Full Text] [Related]
16. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR.
Daitoku H; Yamagata K; Matsuzaki H; Hatta M; Fukamizu A
Diabetes; 2003 Mar; 52(3):642-9. PubMed ID: 12606503
[TBL] [Abstract][Full Text] [Related]
17. Insulin inhibits the activation of transcription by a C-terminal fragment of the forkhead transcription factor FKHR. A mechanism for insulin inhibition of insulin-like growth factor-binding protein-1 transcription.
Tomizawa M; Kumar A; Perrot V; Nakae J; Accili D; Rechler MM
J Biol Chem; 2000 Mar; 275(10):7289-95. PubMed ID: 10702299
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.
Guo S; Rena G; Cichy S; He X; Cohen P; Unterman T
J Biol Chem; 1999 Jun; 274(24):17184-92. PubMed ID: 10358076
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt.
del Peso L; González VM; Hernández R; Barr FG; Núñez G
Oncogene; 1999 Dec; 18(51):7328-33. PubMed ID: 10602488
[TBL] [Abstract][Full Text] [Related]
20. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors.
Kops GJ; Medema RH; Glassford J; Essers MA; Dijkers PF; Coffer PJ; Lam EW; Burgering BM
Mol Cell Biol; 2002 Apr; 22(7):2025-36. PubMed ID: 11884591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
